Fig. 1From: The role of dosimetry and biological effects in metastatic castration–resistant prostate cancer (mCRPC) patients treated with 223Ra: first in human studya) anterior planar 223Ra image, b) anterior, c) posterior planar 99mTc-MDP images; d) 223Ra and 99mTc-MDP co-registered images; e) ROIs identified on the calculated DRR; f) target volumes into FchPET images before and after treatment with 223RaBack to article page